Dr Simon ChenCataract & Retina Surgeon
LocationFor referrersRefer a patientRequest an appointment

Tamsulosin and cataract surgery: what should you tell your surgeon?

Tell your cataract surgeon if you take tamsulosin, or have taken it in the past. This medicine can change how the iris behaves during cataract surgery, even after treatment has stopped. Knowing beforehand helps the team prepare.

Do not stop or change a prescription yourself. Your eye surgeon and the doctor who prescribes it can decide whether any change is appropriate; stopping tamsulosin does not reliably remove the surgical risk.

Written by MBBS, BSc(Hons), FRANZCO

Cataract and retinal surgeon, Vision Eye Institute Chatswood, Sydney

What is floppy iris syndrome?

Intraoperative floppy iris syndrome, usually shortened to IFIS, describes how the iris can behave during an operation. The iris is the coloured part of the eye. Its central opening, the pupil, gives the surgeon access to the cloudy lens behind it during cataract surgery.

Normally, dilating drops help keep this opening wide. With IFIS, the iris may billow in the fluid used during surgery, move towards or through a surgical incision, and allow the pupil to become smaller as the operation proceeds. These features can occur in different combinations and degrees.

A smaller pupil leaves less room to see and work on the lens behind the iris. Pupil narrowing is one feature of IFIS; a small pupil alone does not establish the diagnosis.

IFIS is a surgical behaviour, rather than something you can diagnose by looking in the mirror. It does not mean the medicine has caused a cataract, or that every person taking it will have a difficult operation.

Which medicines should I mention?

Tamsulosin is an alpha blocker, commonly prescribed for urinary symptoms associated with an enlarged prostate. It also affects the muscle that helps widen the pupil.

In Australia, Flomaxtra contains tamsulosin. Flomax is a name you may see overseas. Duodart contains both tamsulosin and dutasteride, so a combination medicine matters too. Check the active ingredients on your packet rather than relying only on the brand name.

Other alpha blockers, including alfuzosin, doxazosin, terazosin and silodosin, have also been linked with IFIS. The evidence is strongest for tamsulosin, and the risk is not identical across medicines. This is a reason to share your medication history, not to switch treatments yourself.

Tell the team about all medicines, including treatments for sleep, mental health and hair loss. Some observational studies have linked medicines such as benzodiazepines, quetiapine and finasteride with IFIS, but those findings are less consistent and do not establish that a particular prescription will cause a problem. IFIS can also occur without a known alpha-blocker history.

Does past use still matter?

Yes. Tell your surgeon even if you stopped tamsulosin months or years ago. A current medication list may miss an important past exposure.

It is useful to bring the medicine name, roughly when you took it, and when you stopped. You do not need to remember exact dates to raise it. Your GP or pharmacist may be able to help identify an old prescription.

If your first eye has already been operated on, tell the second surgeon about any pupil-expanding device or iris difficulty mentioned afterwards. A straightforward first-eye operation does not remove the need to disclose your medicines before the second.

Should I stop tamsulosin before surgery?

Do not stop it on your own. There is no dependable stopping interval that guarantees IFIS will be prevented. Changes in iris behaviour can persist after the medicine has been discontinued.

Stopping may also allow urinary symptoms to return. Your surgeon and prescribing doctor need to weigh this against any possible surgical benefit. If they recommend a change, ask for a clear plan about which medicine to change, when, and whether it should be restarted.

If you are about to start tamsulosin and already have cataract surgery planned, tell the prescribing doctor and eye surgeon before starting. They can coordinate the timing and treatment choice. Do not delay needed treatment without their advice.

How does the surgeon plan for it?

The surgeon checks how well the pupil dilates, examines the eye and reviews your medication and surgical history. A pupil that opens well in the clinic does not completely rule out IFIS during surgery.

The usual measurements for choosing an artificial lens are still important. Lens implant options are a separate discussion: a history of tamsulosin use does not, by itself, decide which lens is suitable.

Measurements help calculate the power of the lens implant. The medication history and pupil examination help plan how to carry out the operation.

Mention the medicine at your assessment, rather than waiting until the day of surgery. That gives the team time to plan the equipment, technique and discussion of risks. If you remember later, contact the surgical team before the operation.

What can be done during the operation?

The approach depends on how the iris behaves. The surgeon may use medicines to support pupil dilation, a gel-like substance to protect and stabilise tissues, or changes to the fluid settings used during surgery.

If more support is needed, temporary iris hooks or a pupil-expansion ring can hold the opening wider. These devices are removed during the operation. Their use is a planned safety measure in many eyes, rather than a sign that something has gone wrong.

The surgeon can combine approaches according to the pupil and iris behaviour. Not every eye needs a pupil-expanding device.

These measures make it easier to work through the pupil, but they do not remove every risk. The surgeon may also allow extra operating time or adapt the technique as the operation progresses.

Can I still have a good result?

Yes, good results are possible when the team recognises the risk and plans for it. Tamsulosin use alone is not a reason to assume that cataract surgery cannot be done.

IFIS can make an operation more demanding. Potential problems include injury to the iris, a tear in the thin capsule supporting the lens, or extra inflammation afterwards. Some complications require additional treatment or surgery. Your own risk also depends on the cataract, pupil size and other eye conditions.

Studies of prepared surgical teams have reported good outcomes, while modern population studies have not consistently found more recorded complications among tamsulosin users. These findings do not mean that IFIS has disappeared or that an individual operation is risk-free.

Will recovery be different?

If the operation is uncomplicated, the usual cataract surgery recovery advice may apply. If there has been more iris manipulation or a complication, your surgeon may adjust the drops, follow-up or activity advice.

Follow the instructions given for your own eye, including drops, the protective shield and review appointments.

Before you leave, make sure you know how to use your eye drops and whom to contact if a problem develops. Follow the agreed plan for your usual medicines as well; do not make further changes simply because the operation is over.

When should I seek urgent advice?

After cataract surgery, seek urgent advice for worsening or severe eye pain, increasing redness, new or worsening loss of vision, especially if sudden, new flashes or a sudden increase in floaters, or a dark curtain or shadow across your sight.

Contact your surgeon or the surgical team's emergency number promptly rather than waiting for your scheduled review. If you cannot reach them, seek urgent assessment from an ophthalmologist or emergency department. Do not drive yourself if your vision is affected.

References and further reading

  1. Therapeutic Goods Administration: Flomaxtra, Australian Register of Therapeutic Goods entry.
  2. Australian Duodart product information: cataract surgery and IFIS precautions.
  3. Chang and colleagues. Prospective multicenter evaluation of cataract surgery in patients taking tamsulosin. Ophthalmology, 2007.
  4. Chang and colleagues. Prospective masked comparison of IFIS severity with tamsulosin versus alfuzosin. Ophthalmology, 2014.
  5. Chatziralli and colleagues. IFIS: a prospective study of risk factors. Eye, 2016.
  6. Kwak and colleagues. Relationship between tamsulosin use and surgical complications of cataract surgery in elderly patients. Frontiers in Medicine, 2022.
  7. Christou and colleagues. Silodosin as a predisposing factor of IFIS: an observational propensity score-matching cohort study. International Ophthalmology, 2022.
  8. NHS: cataract surgery and when to get help.